Sionna Therapeutics (SION) Amortization of Deferred Charges (2024 - 2026)

Sionna Therapeutics (SION) has 3 years of Amortization of Deferred Charges data on file, last reported at $489000.0 in Q1 2026.

• For the quarter ending Q1 2026, Amortization of Deferred Charges changed 0.41% year-over-year to $489000.0; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (changed 0.05% YoY), and the FY2025 full-year result was $2.0 million, changed 0.0% from the prior year.
• Amortization of Deferred Charges held at $489000.0 in Q1 2026, from $491000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $492000.0 in Q1 2024 to a low of $489000.0 in Q1 2026.
• A 3-year average of $490333.3 and a median of $490000.0 in 2024 frame the typical range for Amortization of Deferred Charges.
• Across the five-year window, Amortization of Deferred Charges increased 0.2% in 2025 and fell 0.41% in 2026, its largest moves.
• Tracing SION's Amortization of Deferred Charges over 3 years: stood at $490000.0 in 2024, then rose by 0.2% to $491000.0 in 2025, then retreated by 0.41% to $489000.0 in 2026.
• Business Quant data shows SION's Amortization of Deferred Charges at $489000.0 in Q1 2026, $491000.0 in Q4 2025, and $490000.0 in Q3 2025.